Literature DB >> 26984835

Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.

Xueyuan Nian1, Zhihui Xu2, Yan Liu2, Jianhong Chen3, Xiaodong Li2, Dongping Xu4,5.   

Abstract

BACKGROUND: The relationship between hepatitis B virus (HBV) mutations in basal core promoter (BCP) and precore (PC) regions and the risk of hepatitis B-related acute-on-chronic liver failure (HB-ACLF) remains uncertain.
METHODS: Databases were searched for papers that were published in English or Chinese until April 31, 2015. The odds ratios (ORs) of HBV mutation were pooled by using a fixed or random-effects model according to heterogeneity.
RESULTS: Data for 13 studies with a total of 1,149 HB-ACLF and 1,867 chronic hepatitis B (CHB) cases were retrieved. Statistically significant summary ORs for HB-ACLF were obtained for T1753V (1.99; 95 % confidence interval 1.30-3.02) and A1762T/G1764A (2.11; 95 %, 1.75-2.54) in the BCP region and for A1846T (3.33; 95 %, 2.23-4.97), G1896A (2.78; 95 %, 2.07-3.74), and G1899A (3.09; 95 %, 1.82-5.25) in the PC region. In subgroup analysis, BCP mutations were found to have higher ORs in age-matched studies, but PC mutations were found to have higher ORs in age-unmatched studies; patients with the mutations in HBV genotype C were more susceptible to HB-ACLF; patients with pre-existing liver cirrhosis had a higher risk of HB-ACLF occurrence. In sensitivity, specificity, and accuracy analysis, A1762T/G1764A had the highest sensitivity (67.43 %); A1762T/G1764A + G1896A triple mutations had the highest specificity (93.70 %); and T1753V + A1762T + G1764A mutation had the highest accuracy (65.42 %).
CONCLUSIONS: HBV T1753V, A1762T/G1764A, A1846T, G1896A, and G1899A mutations are correlated with an increase in the risk of HB-ACLF. These mutations alone and in combination may be predictive of the susceptibility of patients with CHB to developing HB-ACLF.

Entities:  

Keywords:  Acute-on-chronic liver failure; Hepatitis B virus; Meta-analysis; Mutation

Mesh:

Substances:

Year:  2016        PMID: 26984835     DOI: 10.1007/s12072-016-9716-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  31 in total

Review 1.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

2.  Enhanced replication of hepatitis B virus with frameshift in the precore region found in fulminant hepatitis patients.

Authors:  Jun Inoue; Yoshiyuki Ueno; Yuta Wakui; Koji Fukushima; Yasuteru Kondo; Eiji Kakazu; Masashi Ninomiya; Hirofumi Niitsuma; Tooru Shimosegawa
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

3.  [Analysis of hepatitis B virus mutations in 20 patients with HBV-related acute-on-chronic liver failure and 19 patients with chronic hepatitis B].

Authors:  Zhengang Zhao; Tao Han; Yingtang Gao; Ye Zhang; Tong Liu; Li Jing; Ha Guo
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2014-03

4.  Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan.

Authors:  Fuminaka Sugauchi; Etsuro Orito; Tomoyoshi Ohno; Yasuhito Tanaka; Atsushi Ozasa; Jong-Hon Kang; Joji Toyoda; Tomoyuki Kuramitsu; Kazuyuki Suzuki; Eiji Tanaka; Yoshihiro Akahane; Takafumi Ichida; Namiki Izumi; Kazuaki Inoue; Hiromi Hoshino; Shiro Iino; Hiroshi Yotsuyanagi; Shinichi Kakumu; Eiichi Tomita; Takeshi Okanoue; Shuhei Nishiguchi; Yoshikazu Murawaki; Keisuke Hino; Morikazu Onji; Hiroshi Yatsuhashi; Michio Sata; Yuzo Miyakawa; Ryuzo Ueda; Masashi Mizokami
Journal:  Hepatol Res       Date:  2006-09-07       Impact factor: 4.288

5.  A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.

Authors:  Margaret T Chen; Jean-Noel Billaud; Matti Sällberg; Luca G Guidotti; Francis V Chisari; Joyce Jones; Janice Hughes; David R Milich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

6.  Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

Authors:  Sameer Parekh; Fabien Zoulim; Sang Hoon Ahn; Adrienne Tsai; Jisu Li; Shigenobu Kawai; Nasser Khan; Christian Trépo; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

Authors:  Robert Y m Chen; Ros Edwards; Tim Shaw; Danni Colledge; William E Delaney; Harriet Isom; Scott Bowden; Paul Desmond; Stephen A Locarnini
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

8.  Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.

Authors:  Chun-Jen Liu; Jia-Horng Kao; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen
Journal:  J Med Virol       Date:  2004-04       Impact factor: 2.327

9.  Hepatitis B Virus e Antigen Variants.

Authors:  Shuping Tong; Kyun-Hwan Kim; Charles Chante; Jack Wands; Jisu Li
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more
  5 in total

1.  A comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeutics.

Authors:  Yi Shen; Xulin Wang; Sheng Zhang; Gang Qin; Yanmei Liu; Yihua Lu; Feng Liang; Xun Zhuang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

2.  The Effect of Modified Sini Decoction on Survival Rates of Patients with Hepatitis B Virus Related Acute-on-Chronic Liver Failure.

Authors:  Jian-Xing Luo; Yang Zhang; Xiao-Yu Hu; Chang Yu
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-24       Impact factor: 2.629

Review 3.  Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes.

Authors:  Qian Li; Jun Wang; Mengji Lu; Yuanwang Qiu; Hongzhou Lu
Journal:  Front Microbiol       Date:  2020-12-07       Impact factor: 5.640

4.  Artificial liver support system therapy in acute-on-chronic hepatitis B liver failure: Classification and regression tree analysis.

Authors:  Kaizhou Huang; Feiyang Ji; Zhongyang Xie; Daxian Wu; Xiaowei Xu; Hainv Gao; Xiaoxi Ouyang; Lanlan Xiao; Menghao Zhou; Danhua Zhu; Lanjuan Li
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

5.  Genotypes and Hot Spot Mutations of Hepatitis B Virus in Northwest Chinese Population and Its Correlation with Diseases Progression.

Authors:  Wei Wang; Yi Shu; Han Bao; Wenliang Zhao; Weihua Wang; Qin Wang; Xiaoying Lei; Daxiang Cui; Zhen Yan
Journal:  Biomed Res Int       Date:  2019-12-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.